Immunovant Earnings
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
30.47+0.21 (+0.69%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 30.47 0.00%
Immunovant earnings summary
In its most recent report on Aug 6, 2026 (Q1 2027), IMVT posted EPS of $-0.75. Across the last 16 reports, IMVT shares moved an average of 4.2% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
IMVT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.75 | — | +4.7% |
| May 20, 2026 | — | $-0.72 | — | -2.5% |
| Feb 6, 2026 | — | $-0.61 | — | -4.8% |
| Nov 10, 2025 | — | $-0.73 | — | -4.8% |
| Aug 11, 2025 | — | $-0.71 | — | +0.1% |
| May 29, 2025 | — | $-0.63 | — | +12.9% |
| Feb 6, 2025 | — | $-0.76 | — | -0.4% |
| Nov 7, 2024 | — | $-0.74 | — | -13.1% |
| Aug 6, 2024 | — | $-0.60 | — | +2.9% |
| May 29, 2024 | — | $-0.50 | — | -0.9% |
| Feb 12, 2024 | — | $-0.36 | — | -0.4% |
| Nov 9, 2023 | — | $-0.45 | — | +3.6% |
| Aug 10, 2023 | — | $-0.57 | — | -8.9% |
| May 22, 2023 | — | $-0.46 | — | -1.9% |
| Feb 3, 2023 | — | $-0.49 | — | +3.8% |
| Nov 4, 2022 | — | $-0.41 | — | +0.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.